Search

Your search keyword '"Peters, Max"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Peters, Max" Remove constraint Author: "Peters, Max" Database Academic Search Index Remove constraint Database: Academic Search Index
54 results on '"Peters, Max"'

Search Results

2. External validation of a risk model predicting failure of salvage focal ablation for prostate cancer.

3. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.

4. Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic.

5. Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score

6. Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience.

7. Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis.

8. Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer.

9. Evaluation of functional outcomes after a second focal high‐intensity focused ultrasonography (HIFU) procedure in men with primary localized, non‐metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry

10. MRI-Guided Ultrafocal Salvage High-Dose-Rate Brachytherapy for Localized Radiorecurrent Prostate Cancer: Updated Results of 50 Patients.

11. MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study.

12. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.

13. MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.

14. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.

15. Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.

16. A Canadian center's experience on whole-gland salvage therapy for radio-recurrent prostate cancer with various modalities.

17. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.

18. Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer.

19. The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon.

20. Comparative cost-effectiveness of focal and total salvage 125I brachytherapy for recurrent prostate cancer after primary radiotherapy.

21. Strain localization in ductile rocks: A comparison of natural and simulated pinch-and-swell structures.

22. Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.

23. Rectal dose constraints for salvage iodine-125 prostate brachytherapy.

24. Urethral and bladder dosimetry of total and focal salvage Iodine-125 prostate brachytherapy: Late toxicity and dose constraints.

25. Design and Synthesis of Artificial Nucleobases for Sequence‐Selective DNA Recognition within the Major Groove.

26. Boudinage as a material instability of elasto-visco-plastic rocks.

28. Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review.

29. Reply to Zhipeng Mai's Letter to the Editor re: Taimur T. Shah, Max Peters, David Eldred-Evans, et al. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry. Eur Urol 2019;76:98–105

30. In Reply to David and Kamrava.

32. Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases.

33. Focal Salvage Treatment of Radiorecurrent Prostate Cancer: A Narrative Review of Current Strategies and Future Perspectives.

34. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.

35. Likert vs PI‐RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer.

37. Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multi‐centre cohort study evaluating the role of Inflammatory Markers In patients presenting with acute ureteric Colic (MIMIC) study

39. An easy-to-use scoring index to determine severity of mitral regurgitation by 2D echocardiography in clinical practice.

40. Deformation at the frictional-viscous transition: Evidence for cycles of fluid-assisted embrittlement and ductile deformation in the granitoid crust.

41. Feasibility and first results of the 'Trials-within-Cohorts' (TwiCs) design in patients undergoing radiotherapy for lung cancer.

42. Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: A nationwide population-based study.

43. Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.

44. Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?

45. The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis.

46. Functionele en oncologische uitkomsten van salvage cryochirurgie voor lokaal recidief prostaatcarcinoom na radiotherapie.

47. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.

48. Severe lymphopenia acquired during chemoradiotherapy for esophageal cancer: Incidence and external validation of a prediction model.

49. Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy.

50. Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.

Catalog

Books, media, physical & digital resources